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Abstract
Spreading depolarizations (SD) are waves of abrupt, near-complete breakdown of neuronal transmembrane ion gradi-
ents, are the largest possible pathophysiologic disruption of viable cerebral gray matter, and are a crucial mechanism of
lesion development. Spreading depolarizations are increasingly recorded during multimodal neuromonitoring in neuro-
critical care as a causal biomarker providing a diagnostic summary measure of metabolic failure and excitotoxic injury.
Focal ischemia causes spreading depolarization within minutes. Further spreading depolarizations arise for hours to days
due to energy supply-demand mismatch in viable tissue. Spreading depolarizations exacerbate neuronal injury through
prolonged ionic breakdown and spreading depolarization-related hypoperfusion (spreading ischemia). Local duration of
the depolarization indicates local tissue energy status and risk of injury. Regional electrocorticographic monitoring
affords even remote detection of injury because spreading depolarizations propagate widely from ischemic or
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metabolically stressed zones; characteristic patterns, including temporal clusters of spreading depolarizations and per-
sistent depression of spontaneous cortical activity, can be recognized and quantified. Here, we describe the experimental
basis for interpreting these patterns and illustrate their translation to human disease. We further provide consensus
recommendations for electrocorticographic methods to record, classify, and score spreading depolarizations and asso-
ciated spreading depressions. These methods offer distinct advantages over other neuromonitoring modalities and allow
for future refinement through less invasive and more automated approaches.
Keywords
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tion, spreading ischemia, brain trauma, focal ischemia, subarachnoid hemorrhage, intracerebral hemorrhage, epilepto-
genesis, epilepsy, cerebral blood flow, brain edema, vasospasm, global ischemia, neurovascular coupling, neuroprotection,
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Introduction
Spreading depolarization (SD) is the generic term for
pathologic waves of abrupt, sustained mass depolariza-
tion that propagate at velocities of 1.7–9.2mm/min in
gray matter of the brain.1–4 It originates in neurons5,6
and is characterized by active propagation of an
abrupt, near-complete breakdown of the neuronal
transmembrane ion gradients, in contrast to the slow
breakdown that can be observed in any cell of the body
before death when there is severe energy depriv-
ation.7–11 The concentration gradient of practically
every investigated small molecule changes between
cytoplasm and interstitial space during SD. These char-
acteristic concentration changes are the largest
observed in live tissue.2 In addition, cell organelles
such as mitochondria undergo marked alterations
during SD.12,13
The other important pathological network event in
the brain is the ictal epileptiform event (IEE). IEE is the
pathophysiological correlate of convulsive and noncon-
vulsive epileptic seizures. As a rule of thumb, changes
during SD are at least ﬁve times greater than those
observed during IEE.14,15 Because the changes of SD
are so large and diverse, numerous options exist to
measure SD in the experimental setting. For example,
SD can be detected via the abrupt extracellular concen-
tration changes of glutamate, potassium, or sodium
using microelectrodes in vivo or in brain
slices,7,8,10,16–19 the large increase in intracellular cal-
cium as measured with calcium imaging,20,21 the cellu-
lar swelling and dendritic beading as observed with
two-photon microscopy,22–25 which is associated with
shrinkage of the extracellular space,10,26–28 the local
decrease in intracellular water mobility as imaged by
diﬀusion-weighted magnetic resonance imaging
(MRI)12,15,29–32 or the release of free energy from the
tissue that is converted to heat (‘‘free energy
starving’’).33,34 Moreover, SD involves astro-
cytes,5,6,35–37 provokes marked microvascular/hemo-
dynamic responses,38–41 activates microglial cells and
inﬂammasome formation and induces cytokine gene
expression.42–44 Thereby, SD creates an interface of
reciprocal interaction between the three super sys-
tems—nervous, vascular, and immune—whenever the
brain is locally injured.2 This interface reaches far
beyond the actual zones of injury because of the spread-
ing nature of SD. The wide array of immense changes
involved in SD suggests that this phenomenon is among
the most fundamental processes of brain pathology.
SD is the mechanism of both pannecrotic and select-
ive neuronal lesion development in gray matter
depleted or deprived of energy, as shown in diverse
disease models and species.45 In adequately supplied
tissue, SD could be slightly injurious,46 innocuous,47
or even protective.48–53 This selectively harmful charac-
ter and the notorious pharmacoresistance of SD in
energy-depleted tissue complicate direct therapeutic
targeting. However, SD monitoring in neurocritical
care oﬀers unprecedented opportunities for disease
characterization and treatment stratiﬁcation to tailor
targeted treatments, following the concept of
Precision (‘‘individualized’’) Medicine.54 Particular
advantages include that SD monitoring can be per-
formed at the bedside, continuously, and in real
time.55 Therefore, it should allow for targeted treat-
ment to begin earlier than with diagnosis based on
any imaging modality or laboratory test because there
are no delays associated with detection of pathology,
laboratory analyses, or patient transport.
The ﬁrst part of this consensus article is devoted to
multimodal monitoring in neurocritical care of trau-
matic brain injury (TBI) and stroke patients.56 The
second part addresses basic properties of SD with a
focus on their clinical relevance. The third part dis-
cusses how newly developing ischemic zones may be
Dreier et al. 3
detected in real-time even when the recording device is
located remotely from the ischemic zone. In the fourth
part, we recommend practical guidelines for the routine
monitoring of SD within the framework of the Co-
Operative Studies on Brain Injury Depolarizations
(COSBID) and multimodal neuromonitoring that
enable its use as a diagnostic summary measure for
disturbances in brain energy metabolism,55 brain
lesion development,45 prognostication,57,58 and tailored
therapy in neurocritical care.
Part 1: Relevance of multimodal
monitoring in neurocritical care
A diagnostic summary measure for disturbances
in brain energy metabolism
Personalized medicine proposes the customization of
healthcare by tailoring medical decisions, practices,
and/or products to the individual patient. In this
model, treatment-responsive modiﬁable biomarkers of
injury serve as diagnostic summary measures to enable
iterative tailored therapy.
Powerful diagnostic summary measures exist for
practically every organ. The brain, however, poses par-
ticular challenges because time from onset of an insult
to damage is shorter than in other tissues, and brain
structure and physiology are exceedingly complex. The
brain is also less accessible to point-of-care diagnostic
procedures and interventions since it lies beneath the
skull and is normally isolated from peripheral
circulation.
An important biomarker would measure disturb-
ances of energy supply and metabolism in pathologic
conditions of the brain such as global ischemia, hypo-
glycemia, TBI, and stroke, the leading cause of major
disability and third leading cause of death in the
world.59–61 Acute disturbances of brain energy metab-
olism in a fully conscious patient can often be detected
via history and neurological exam by the treating phys-
ician;15 however, in patients with reduced consciousness
from injuries or sedatives, neurologic assessments often
fail to detect secondary injury. Thus, diagnosis of sec-
ondary injury is often delayed in the intensive care set-
ting, and treatment is not provided at the appropriate
time despite the availability of suitable interventions.62
Diagnostic summary measures are useful precisely
for these situations. The ideal measure of disturbed
brain energy metabolism should: (a) be available at
the bedside in real-time to allow for intervention
before tissue damage occurs; (b) have high sensitivity
and speciﬁcity with minimal interference from other
signals; (c) be non- or minimally invasive to reduce
the risk of side-eﬀects; (d) be procedurally simple to
implement and durable, with minimal possibility of
failure from patient movements or manipulations; (e)
include automated analysis to minimize human work-
load and allow pre-speciﬁed diagnostic criteria to trig-
ger an alarm; and (f) respond rapidly to treatment and
reﬂect treatment eﬃcacy in real-time. While candidate
summary measures should strive to achieve these ideal
requirements within realistic limits, their development
takes time and necessitates progressive incremental
advances. Monitoring of the brain should thus be
regarded as a modular or building-block construct in
which individual parts/concepts are continually added
and reﬁned, while failed or obsolete ones are removed.
Multimodal monitoring of the brain
Multimodal continuous bed-side monitoring has
already long been applied routinely in neurocritical
care. The modalities most widely used at present are
intracranial pressure (ICP), cerebral perfusion pressure
(CPP), oxygen availability (local tissue partial pressure
of oxygen [ptiO2]), and scalp electroencephalography
(EEG).63 Only recently have electrographic approaches
been extended to include intracranial electrocorticogra-
phy (ECoG) as a method to monitor SD. The focus of
the present article is therefore on SD, but it is empha-
sized that SD is only one promising element in concert
with others to build and improve eﬀective diagnostics
through multimodal neuromonitoring. Given that the
diﬀerent modalities are not mutually exclusive but may
actually be complementary,64 here we describe the
state-of-the-art recording and analysis of SDs within
the framework of multimodal monitoring in neurocri-
tical care.
Neurocritical care as a systems process
It is beyond the scope of the present article to discuss
the other measures of multimodal monitoring in detail.
Instead, the reader is referred to the following
reviews.63,65–68 Nonetheless, it may be mentioned that
each of those modalities faces several fundamental chal-
lenges for advancing application: (a) What exactly are
they measuring: cause or eﬀect? (b) How, where, and
when should they be recorded to extract the most clin-
ically relevant information? (c) What are the most rele-
vant thresholds or derived summary measures for
treatment and prognosis? (d) What are the appropriate
interventions to restore physiology? and (e) Does moni-
toring or associated intervention impact outcome?63
In general, the philosophy behind patient monitor-
ing in critical care is that clinical outcome should be
improved through an iterative, bidirectional modula-
tion to restore diagnostic summary measures to a
physiological range, unless there are good reasons to
allow a set point adjustment. But this approach is
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intrinsically diﬃcult because the clinician seeking better
outcomes has to choose among many individual inter-
ventions, each modifying several monitored variables.
Furthermore, many complex interactions make it hard
to distinguish unequivocally if the changes observed in
multimodal monitoring are a consequence of feedback
mechanisms (both physiological and pathological), or
the clinical interventions themselves. In this context,
simple causal reasoning becomes diﬃcult because diag-
nosis inﬂuences therapy and therapy inﬂuences diagno-
sis, leading to circular arguments.
Thus, the compound value of the current concept of
neurocritical care and emergency medicine may be
revealed in a historical perspective from decade to
decade, but the search for single diagnostic or thera-
peutic measures responsible for improvement is at best
exceedingly diﬃcult, and at worst may be misguided.
For example, the general value of neurocritical care and
emergency medicine is supported by a weighted lin-
ear regression analysis that revealed a decline in case-
fatality rate of aneurysmal subarachnoid hemorrhage
(aSAH) by 8% per decade between 1960 and 1992.
There was also an increase in the proportion of patients
who recovered independent function.69 Mortality of
TBI declined in a similar fashion at a rate of 9% per
decade from 1970 to 1990.70 However, the controversies
begin when single modalities of modern management
are considered, such as ICP control in TBI and aSAH.
On one hand, the only randomized controlled trial on
ICP monitoring in patients with severe TBI failed.71
Yet, Gerber et al.72 observed that adherence to the
Brain Trauma Foundation guidelines in New York
State between 2001 and 2009 was associated with fur-
ther decline in the 2-week case-fatality rate from 22%
to 13%. The authors mainly attributed this improve-
ment to vigorous ICP control, consistent with the gen-
eral view in the ﬁeld that ICP control cannot be
dispensed with.63,65,66,73
Increased ICP can cause tissue damage by brain her-
niation and severe reduction in regional cerebral blood
ﬂow (rCBF). Hence, common sense alone dictates that
ICP should remain below a certain threshold. However,
the threshold is likely a graded one, may vary for indi-
vidual patients, and may be a function of time in add-
ition to absolute level.74 Further questions are how best
to maintain the physiologic range and whether the
beneﬁts outweigh the costs. In the clinic, the pillar of
ICP control is eﬀective sedation, but sedation often
necessitates intubation and ventilation. Each day of
mechanical ventilation increases the risk of pneumo-
nia,75 which is in turn associated with worse outcome
in TBI and stroke including aSAH.76–79 Unfortunately,
neither modulation of the yet largely enigmatic mech-
anisms of the central nervous system (CNS)-injury
induced immunodepression syndrome (CIDS) nor
preventive antibiotic treatment seem to be viable
options for the prevention of pneumonia. CIDS predis-
poses stroke and TBI patients to pneumonia,80–83 but
may protect the brain through inhibition of autoaggres-
sion; administration of preventive antibiotics failed to
improve functional outcome in patients with
stroke.80,84–87 This illustrates how diagnostic measures
can result in therapeutic decisions that solve one prob-
lem but may create others. The net gain or loss
on the intervention is accordingly complex and often
diﬃcult to interpret. This example involving ICP con-
trol is particularly interesting because the original prob-
lem is intracranial whereas the new one, that is,
pneumonia, is extracranial, and the whole process
involves not only one but several disciplines, including
neurointensivists, neurosurgeons, anesthetists, infec-
tious disease specialists, immunologists, hospital
hygienists, and nurses.
These brief sketches introduce another more general
problem that arises from the ever-increasing complexity
of monitoring, interventions, and complications: the
intensity of labor and resource utilization and asso-
ciated risk of human error in neurocritical care. The
list of potential complications alone is impressive. For
example, aSAH was found to be associated with
around 20 relevant intracranial and more than 30 rele-
vant extracranial complications.76,77 On top of this,
there are numerous side eﬀects of a wide range of medi-
cations. In order to maintain overview and to allow
comparative studies, it is therefore mandatory to
employ simple, logical, and practically useful standards
and recommendations that are updated periodically at
the level of professional societies and local institutions.
The second goal of this article is therefore to establish
current standards and recommendations for monitor-
ing of SDs in neurocritical care.
Such standards of monitoring brain pathology may
complement alternate representations of complex data
sets88 with the ultimate ambitious goal of a whole-
system approach to neurocritical care. Such an
approach removes some obstacles by replacing a
‘‘black box’’ that only shows outputs devoid of context,
with information about the evolution of disease pro-
cess, the homeostatic responses, and therapeutic inter-
ventions, along with means to tease apart the eﬀects of
these interactions. Ideally, this information would be
quantitative. Then, monitoring would imply construct-
ing a dynamical model of the patient-pathology-
intervention triad, which carries three consequences.
First, ﬁnding such a model would beneﬁt from avail-
able formal methods to describe, analyze, predict, and
ultimately control the system under study. Second,
model-based observation is in itself a natural platform
for discovery (hypothesis generation and testing). And
third, a uniﬁed model of patient, disease process, and
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selective interventions is the very realization of perso-
nalized medicine. In a practical sense, this process of
model building makes data analysis a continuous and
parallel activity to acquiring the data. ‘‘Monitoring’’
would not just mean ‘‘data acquisition’’ anymore, it
would become synonymous with selecting a subset of
well-understood quantities to guide clinical decision
making, case-by-case.
Part 2: Basic properties of SD in the clinic
Spectrum of diseases
There is unequivocal electrophysiological evidence that
SDs occur abundantly in the human brain in numerous
diseases such as TBI,57,89–92 spontaneous intracerebral
hematoma (ICH),90,93,94 aSAH,55 delayed cerebral
ischemia (DCI) after aSAH55,58,95,96 and malignant
hemispheric ischemic stroke (MHS).4,97 Further, ima-
ging studies of changes in rCBF or its surrogates and
magnetoencephalography strongly suggested that SD is
the pathophysiological correlate of the migraine
aura.40,98–101 In migraineurs, it may trigger migraine
headache.15,102–104
Signatures of SD in the human brain
SD propagates in gray matter of the human brain at a
rate between 1.7 and 9.2mm/min as assessed by laser
speckle imaging of rCBF and imaging of the intrinsic
optical signal (IOS) in the operating room.4 In neuro-
critical care, long-term monitoring of SD can be
achieved with direct current ECoG (DC-ECoG), the
same technique commonly used in preclinical studies.
The designation of DC-ECoG is equivalent to full-
band, indicating that the recording ampliﬁer does not
ﬁlter any low frequency components of the voltage
signal and is therefore compatible with measuring to
a theoretical limit of 0Hz, known as the DC oﬀset.
Practically, DC shifts or potentials are synonymous
with slow potentials and refer to low frequency signals
<0.05Hz. In DC-ECoG then, SD is observed as a large
negative slow potential, or DC shift, in the frequency
range of <0.05Hz, that occurs with sequential onset at
adjacent recording sites (Figures 1 and 2).91,95,105 This
negative DC shift emanates from diﬀerences in depolar-
ization between soma and dendrites.106
In electrically active tissue, SD usually causes
spreading depression of spontaneous activity109
Figure 1. The full-band ECoG signal contains information on both the negative DC shift that identifies SD and the SD-induced
depression of activity. In subdural ECoG recordings using a DC amplifier, SD is observed as a characteristic, abruptly developing
negative shift of the slow potential. Note that negative is up for ECoG recordings shown in all figures. The negative DC shift is
necessary and sufficient for identification of SD, and the duration of the negativity is a measure of the metabolic and excitotoxic burden
imposed on tissue by SD (steps A and B). In recordings with an AC amplifier with lower frequency limit of 0.01Hz, the negative DC
shift is distorted but is observed in the near-DC frequency band between 0.01 and 0.05Hz as a multi-phasic slow potential change that
serves to identify SD (step C). The depressive effect of SD on spontaneous activity is assessed in the higher frequency band between
0.5 and 45Hz (step D). ECoG frequencies are given on a logarithmic scale in the left panel. Note that the upper frequency limit of the
full-band signal depends on the sampling rate, fs, and the bandwidth merely ranges from 0 to the Nyquist frequency, 0.5 fs.
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because the sustained depolarization exceeds the inacti-
vation threshold for the action potential generating
channels.110 At a given point in the tissue, the depres-
sion nevertheless outlasts the depolarization, suggesting
that it is maintained by other mechanisms that aﬀect
synaptic function such as: (a) intracellular zinc and
calcium accumulation, (b) extracellular adenosine accu-
mulation, and/or (c) Na,K-ATPase activation
(Figures 1 and 2(a)).111–114 Spontaneous activity of
the brain within the alternating current (AC) range
exceeding 0.5Hz has an amplitude of at least an order
of magnitude smaller than the giant DC shift of SD.
Figure 2. Spreading depolarization causes spreading depression in electrically active (a) but not in electrically inactive (b) tissue
(¼isoelectric SD). Recordings of a 53-year-old female with a World Federation of Neurosurgical Societies (WFNS) grade 5, Fisher
grade 3 aSAH due to rupture of a middle cerebral artery (MCA) aneurysm. (a) SD is observed as an abrupt, large negative DC shift in
raw ECoG recordings (band-pass: 0–45Hz, traces 3–6). The DC shift shows a sequential onset in adjacent electrodes because it
spreads in the tissue at a rate between 1.7 and 9.2mm/min (oblique arrows).4 To illustrate the principle of a band-pass filter a circuit
diagram of an analog filter is shown between traces 6 and 7 (C¼ capacity, L¼ inductance, R¼ ohmic resistance, Vin¼ input, and
Vout¼ output voltage). A digital band-pass filter with lower frequency limit of 0.5 Hz and upper frequency limit of 45Hz is applied to
the full-band ECoG to separate the spontaneous activity from lower frequencies on the one hand and ambient AC electrical noise at
50/60Hz on the other (traces 7–10). Spreading depression is observed as a rapid rundown of spontaneous activity. Note that the
spreading depression in traces 7–10 outlasts the DC shift durations in traces 3–6 at all recording electrodes. The recordings in (a)
suggest that the cortical region underlying the electrode strip is more or less adequately supplied with energy. This is based on at least
five arguments: (i) the negative DC shifts are relatively short-lasting at all recording sites (traces 3–6); (ii) the presence of spontaneous
activity before SD indicates that rCBF must be above 15–23mL/100 g/min before SD (traces 7–10)107; (iii) spontaneous activity
quickly recovers from spreading depression at all recording sites; (iv) ptiO2 is within the normal range as recorded with an intra-
parenchymal oxygen sensor (Licox, Integra Lifesciences Corporation, Plainsboro, NJ, USA) (trace 2) and shows a predominantly
hyperoxic response to SD (brown bar); and (v) CPP is stable within the normal range before, during and after the SD (trace 1). (b)
During the following night, the patient developed a cluster of recurrent SDs with persistent spreading depression of activity.
Accordingly, the SDs (traces 3–6) now occur in electrically inactive tissue (traces 7–10). Such SDs are denoted with the adjective
‘‘isoelectric.’’ The comparison of the SDs (DC shifts in traces 3–6) between (a) and (b) illustrates that SDs associated with and without
spreading depression (traces 7–10) are ‘‘of the same nature’’ as already pointed out by Lea˜o in 1947.108 However, the prolongation of
the negative DC shifts of the clustered SDs in (b) (cf. particularly SD2) compared to the isolated SD in (a) indicates that there is now
some degree of energy compromise in the recording area. Note also that the response of ptiO2 to SD has changed from (a) to (b).
Each episode of SD in electrode 3 is now associated with an initial decrease of ptiO2 (brown bars) and subsequent increases are
reduced or absent in (b) in contrast to the isolated SD in (a).95,96 Between traces 6 and 7, a scheme of the standard subdural electrode
strip is shown.
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High-pass ﬁltering at 0.5Hz is therefore necessary to
separate the spontaneous activity from lower frequen-
cies to assess changes during SD. Often, as shown in
Figures 1 and 2(a), a band-pass ﬁlter with a lower fre-
quency limit of 0.5Hz and an upper frequency limit of
45Hz is used to additionally remove 50/60Hz ambient
AC electrical noise. A typical sampling rate in such
clinical recordings is 200Hz.
Theoretically, SD could also be measured by micro-
electrodes sensitive to any of the neurotransmitters,
ions, metabolites, or signaling molecules that change
in the extracellular space during SD. Glutamate is of
particular interest because of its role in the concept of
excitotoxicity, and the extracellular rise in glutamate is
synchronous with the onset, sustainment, and reso-
lution of the negative DC shift of SD.16 However, glu-
tamate can only be measured long-term in the clinic by
microdialysis, and currently used microdialysis is infer-
ior to ECoG because the temporal resolution is 720,000
times lower.115,116 Yet, rapid sampling microdialysis
could oﬀer new solutions. Rapid sampling technology
revealed, for example, an abrupt increase in extracellu-
lar lactate and a decrease in glucose as part of the meta-
bolic signatures of SD in patients with TBI.117,118
Differentiation between SD and IEE in the clinic
In human ECoG recordings, IEE and SD are easily
distinguished because the negative DC shift of SD is
several times larger than the negative DC shift of an
IEE.58 Moreover, ictal epileptiform ﬁeld potentials
are characterized by rhythmic discharges, whereas SD
typically causes depression of spontaneous activity
(Figures 1 and 2(a)). IEEs can spread at either a
similar rate to SDs or at a much faster rate of around
90mm/min.58 Spreading convulsion is a peculiar hybrid
phenomenon between IEE and SD, characterized by
epileptiform ﬁeld potentials on the tailing end of the
DC shift instead of the usually triggered spreading
depression (Figure 3(d)).40,57,58
Similar to SDs, IEEs often occur in patients with
severe cerebral injuries in both the acute and subacute
period.122 However, SDs are more common than
IEEs.58,119 The estimated incidence of IEEs in continu-
ous EEG or ECoG recordings during the ﬁrst week
after the initial insult can be as high as 23% in
TBI,123 38% in aSAH,58,122,124 31% in ICH,125 and
27% in ischemic stroke.126 SDs in the acute and sub-
acute period were recorded in about 56% of patients
with TBI,57,90 60–70% of patients with ICH,3,94
70–80% of patients with aSAH,55,58 and practically
100% of patients with MHS.4,97 The human ﬁndings
agree with experimental and theoretical studies
that both IEEs and SDs can result from an acute
increase in neuronal excitability and/or an energy
supply-demand mismatch.110,127–131 Accordingly, prop-
erly monitored patients with acute status epilepticus
often show not only IEEs but also SDs, though there
is great variability in spatio-temporal patterning of
these activities.119 By contrast, chronically increased
excitability causes IEEs but has an inhibitory eﬀect
on SDs in animals.132–134
Whether SDs have a role in epileptogenesis is not yet
clear. Epileptogenesis is the long-lasting plastic process
with early interictal electrophysiological changes that
ultimately leads to the delayed development of chronic
epilepsy.135–138 This process is still poorly understood.
One of its key features is a strikingly selective loss of
certain neuron types. SDs facilitate neuronal death and,
interestingly, early SDs showed a signiﬁcant association
with the development of late epilepsy in patients with
aSAH.58 SDs in the early aftermath of brain injury
could thus potentially serve as causal biomarkers of
epileptogenesis, but this deserves further study.
Table 1 gives a few simple deﬁnitions that may be help-
ful in the standardization of further clinical research on
the relationship between SDs, IEEs, and epileptogen-
esis after acute cerebral injuries.
Normal and inverse hemodynamic response to SD
The normal hemodynamic response to SD in naı¨ve,
healthy tissue of most investigated species including
humans40,98,140 consists of a prominent short-lasting
hyperemia (cf. rCBF at optode 3 in Figure 4) followed
by a mild, long-lasting oligemia.151 Closer inspection
shows even four hemodynamic phases of SD as
reviewed recently.141 SD causes neither signiﬁcant cel-
lular energy shortage nor any histologically obvious
cellular damage in adequately perfused tissue when
the neurovascular coupling is intact47,152 although
tissue hypoxia may develop in distant territories of cor-
tical capillaries because the cerebral metabolic rate of
oxygen (CMRO2) markedly rises during SD.
23,151
By contrast, SD can trigger severe focal ischemia in
animals in moderately ischemic or even adequately per-
fused tissue when neurovascular coupling is impaired
and the hemodynamic response to SD is inverted. In
this case, SD induces initial, severe microvascular con-
striction, instead of vasodilatation, which persists as
long as the tissue remains depolarized.2,38,39,141,154–157
This type of focal ischemia propagates together with
the neuronal depolarization wave and is therefore
referred to as spreading ischemia.39,158 Strictly speak-
ing, the term spreading ischemia only describes the SD-
induced initial perfusion deﬁcit (cf. rCBF at optode 5 in
Figure 4) when it leads to a prolonged negative DC
shift (cf. DC/AC-ECoG at electrode 5 in Figure 4).2,143
Across tissue, hemodynamic responses to SD often
show a continuum from an inverse ischemic response to
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Figure 3. Instructions how to identify SDs and score depression durations. (a) This illustrates the routine calculations based on
monopolar recordings. Raw monopolar ECoG recordings of two neighboring electrodes are shown in the upper two traces (band-
pass: 0–45Hz). The negative DC shift of SD is assessed in these recordings. Near-DC/AC-recordings can be derived from the raw
recordings using a digital band-pass filter between 0.01 and 45Hz (traces 3 and 4) and AC-ECoG recordings using a digital bandpass
filter between 0.5 and 45Hz (traces 5 and 6) (also compare Figure 1). Spreading depression is observed in the AC-ECoG recordings as
a rapidly developing reduction in the amplitudes of spontaneous activity which spreads together with SD between adjacent recording
sites. The squared spontaneous activity is also called AC-ECoG power. The power in contrast to the simple AC-ECoG signals can be
used as a measure to quantify local brain activity over time because there are no negative and positive values that neutralize each
other. The integral of the power is based on a method of computing time integrals over a sliding window according to a time decay
function. This mathematical procedure provides a smoothed curve easing visual assessment of changes in AC-ECoG power. The
method has become standard to score depression durations of SD55,91,97 and is also useful in the screening for IEEs.58,119 Depression
durations of SD are scored beginning at the initial decrease in the integral of power and ending at the start of the recovery phase (cf.
*). The caveat is added that the interrater reliability of this method is high in our experience but there remains a certain degree of
subjectivity. Table 2 gives the formulas for the calculations in LabChart (ADInstruments, Oxford, UK). (b) SD-induced depression
durations can be scored in either each of the six monopolar ECoG channels as in (a) or each of the five bipolar ones as in (b) to
determine the longest recorded depression duration of all channels for each SD in minutes. Bipolar recordings have the theoretical
advantage that they are more robust in the clinical setting because the external reference can get lost during patient movements or
nursing procedures. However, this can be prevented when the external reference is secured with collodion-saturated gauze. Although
depression period assessments can vary considerably between the two configurations, they were not consistently greater or lesser for
either; addition of a second active electrode in the bipolar derivation could either augment or dilute effects observed in a single active
electrode.120 TDDDs were similar between mono- and bipolar recordings. This suggests that there is in general no advantage of
bipolar versus monopolar recordings in assessing either the degree or duration of spreading depression. SPCs are even more
distorted in bipolar than in monopolar recordings but they are still sufficient to identify SDs. (c) The local recovery from SD requires
activation of energy-dependent membrane pumps such as Na, K-ATPases. A short-lasting DC shift thus indicates that there is enough
ATP to fuel the local membrane pumps for the recovery from SD at the recording site. This feature renders the local negative DC shift
duration a useful measure for: (i) the local tissue energy status and (ii) the local risk of injury (excitotoxicity) at the recording site.
Accordingly, the upper two traces indicate that the tissue is more energy compromised at electrode 5 than 2 because the negative DC
shift of SD is longer (gray lines). Note that despite the prolonged recovery phase the initial DC deflection still occurs rapidly. The local
information on the energy status is lost when only the near-DC is recorded as in traces 3 and 4. SPCs in near-DC/AC recordings thus
merely serve as an identifier of SD. (d) A spreading convulsion is an SD in which epileptic field potentials arise on the tailing end of the
DC shift.58,109,121
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Table 1. Pragmatic definitions for the assessment of ECoG-recorded SDs, IEEs, and IIC in neurocritical care.
Term Definition
Definition of SD-related variables
Spreading depolarization (SD) Generic term for all waves of abrupt, sustained near-complete breakdown of the neuronal trans-
membrane ion gradients and mass depolarization that propagate at 1.5–9.5mm/min in gray
matter of the brain
Negative DC shift A characteristic, abruptly developing negative shift of the slow potential recorded with a DC
amplifier, often followed by a longer lasting positivity. The negative DC shift is necessary and
sufficient for identification of SD, and the duration of the negativity is a measure of the local
metabolic and excitotoxic burden imposed on tissue by SD. In recordings with an AC amplifier
with lower frequency limit of 0.01Hz, the negative DC shift is distorted but is observed as a
multi-phasic slow potential change (SPC) that serves to identify SD
Negative ultraslow
potential (NUP)
A very long-lasting, shallow negativity of the DC potential with superimposed SDs. Experimentally
associated with incomplete recovery of the typical ion changes after SDs and hence with
developing neuronal injury. NUP may indicate that only a fraction of neurons in the tissue have
repolarized at the recording site and that the remaining fraction is persistently depolarized
Isoelectric SD SD that occurs in electrically inactive tissue (no spreading depression is possible)
Spreading convulsion SD in which epileptic field potentials arise on the tailing end of the DC shift58,109,121
SD Cluster Current working definition of a cluster is the occurrence of at least three SDs occurring within
three or fewer consecutive recording hours139
Spreading depression
of activity
SD-induced reduction in amplitudes of spontaneous activity that runs between adjacent electrodes
Nonspreading
depression of activity
Observed as a simultaneous arrest of spontaneous activity in neighboring electrodes under severe
energy compromise before the occurrence of SD (left panel of Figure 8).15,108 Because the term
is applied specifically in diagnosis of interrupted energy supply, the following criteria have to be
fulfilled additionally: (i) invasive measurements of arterial pressure prove global arrest of the
circulation or (ii) local ptiO2 has fallen to a critical level before nonspreading depression develops.
If tissue is reperfused in time, nonspreading depression is not followed by SD
Persistent spreading
depression of activity
A state of persistently depressed AC-band or high-frequency electrical activity induced and main-
tained by an SD or a series of repetitive SDs
Normal hemodynamic response
to SD
Similar to the electrophysiological signals of SD, also the hemodynamic responses show remarkable
correspondence between humans on the one hand and both rats and pigs on the
other.40,98,105,140–142 The most prominent feature of the normal hemodynamic response to SD is
the pronounced hyperemia. This is variably followed by a mild, long-lasting oligemia.95
Inverse hemodynamic response
(spreading ischemia) to SD
A severe vasoconstriction triggered by SD that causes a steep and almost instantaneous decrease in
local perfusion. In a vicious circle, the perfusion deficit prevents neuronal repolarization and
prolongs the release of vasoconstrictors.2,143,144 In human recordings, spreading ischemia is
identified by severe SD-induced hypoperfusion together with a prolonged negative DC shift of
SD.2,39 Durations of the DC shift and initial hypoperfusion should be determined. Importantly,
hemodynamic responses to SD are not binary, but exist on a continuum between normal and
inverse141,142
Definition of IEE related variables
Seizure The definition of a clinical seizure follows the current guidelines of the International League Against
Epilepsy (ILAE)145
Status epilepticus Refers to convulsive IEEs lasting longer than 5min or if 2 or more convulsive IEEs occur without a
return to baseline in between, or nonconvulsive IEEs for continuous ictal-appearing patterns
lasting 30min or ictal patterns present more than 50% during 1 hr of recording146–148
Ictal epileptiform
event (IEE)
Defined as any spikes, sharp-waves, or sharp-and-slow wave complexes lasting for 10 s or more at
either a frequency of at least 3/s or a frequency of at least 1/s with clear evolution in frequency,
morphology, or recording sites of the electrode strip,58,122,149 which is visible as an increase in
the AC-ECoG power and the integral of the power.58 May occur with or without an overt clinical
correlate.
Ictal-interictal
continuum (IIC)
Repetitive generalized or focal spikes, sharp-waves, spike-and-wave or sharp-and-slow wave com-
plexes lasting for 10 s or more with a frequency between 1 and 3/s without clear evolution in
frequency, morphology, or location122,149
(continued)
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an increasingly normal hyperemic response or the other
way round, as shown, for example, from optodes 3 to 4
to 5 in Figure 4.39 This results from local variations in
condition-related augmentation or, respectively, damp-
ing of various SD-induced vasoeﬀectors along the path
of the wave.2,141 Causative conditions include not only
changes in the milieu of the interstitial ﬂuid39 but also
the basal level of rCBF.157 Experimentally, spreading
ischemia can be the sole cause of widespread cortical
infarcts.159 In the ischemic penumbra, it contributes to
lesion progression.38,154,160 In the clinic, it was identi-
ﬁed in patients with aSAH, TBI, and MHS
(Figure 4).4,95,161
Notably, spreading ischemia might explain at least a
fraction of the CPP-independent drops in ptiO2 in
patients with aSAH and TBI (ptiO2 in Figures 2(b)
and 4).162,163 In the interpretation of ptiO2, however,
it should be borne in mind that decreases might be
observed when the rCBF response is still quite normal
because of the marked increase in CMRO2 imposed
by SD.95,96,151,155
Peculiarities of SD in ischemia
Focal cerebral ischemia is one of the most crucial
among the many triggers of SD.2,108,164,165 Typically,
the ﬁrst SD starts in the ischemic core at one or more
points in the tissue 2–5min after the onset of ische-
mia.107,108,156,160,166,167 Notably, SD does not mark
the onset of cell death, but rather starts the clock on
the countdown to cell death. Speciﬁcally, it marks the
onset of the toxic disturbance in neuronal homeostasis
that initiates the cascades leading to cell death.15,164 If
these disturbances outlast a threshold duration, the so-
called commitment point, neurons will die.11 This
implies that neurons can survive SD in the ischemic
core if the tissue is reperfused and repolarizes before
the commitment point.164,168,169 Conversely, however,
neurons will die if the commitment point is reached,
even if there is subsequent reperfusion, repolarization,
and some recovery of spontaneous activity.164,168
The mechanism of cell death is predominantly necrosis
when neurons experience very long-lasting depolariza-
tion of around 30–60min or longer (Figure 5). This
shifts toward apoptosis and, hence, to slower death
within the necrotic–apoptotic continuum when there
is local reperfusion and recovery from SD after the
commitment point but before 30–60min.169,170 The
commitment point also depends crucially on the abso-
lute local level of perfusion and diﬀers between diﬀerent
types of neurons.171
The initial SD that occurs in severely ischemic tissue
is often denoted with the adjective ‘‘anoxic’’.173
Notably, anoxic SD spreads in a similar fashion to
SD in nonischemic tissue but it may start from multiple
points in the tissue.156,167,174 From a focal ischemic
core, the anoxic SD then spreads against the gradients
of oxygen, glucose, and perfusion into the adequately
supplied surrounding tissue. The full continuum of SD
is observed in this single initial wave, and also in sub-
sequent spontaneous SDs.45 The continuum entails
changing characteristics of the wave determined by
the local conditions of the tissue. Most importantly,
the duration of the depolarization and near-complete
breakdown of ion homeostasis, as indicated by the
negative DC shift, varies from persistent in the ischemic
core to short-lasting in the periphery, since repolariza-
tion requires activation of energy-dependent membrane
pumps such as Na,K-ATPases.135 Short-lasting DC
shifts thus indicate enough ATP at the recording site
to fuel repolarization. This feature renders the negative
DC shift duration a useful measure for (a) the tissue
energy status and (b) the risk of injury (excitotoxicity)
at the recording site (Figures 3 and 5).1,16,91,95,108,115
The concept of the SD continuum is critical to clin-
ical monitoring since many SDs observed in patients
have intermediate characteristics, as opposed to the
two extremes of SD in either severely ischemic or
normal tissue.15 It is also important because there are
large variations in mechanistic aspects and pharmaco-
logical sensitivity of SDs along the continuum, as dic-
tated by local tissue conditions, and these have
Table 1. Continued
Term Definition
Onset seizure/IEE/IIC Clinical seizure/IEE/IIC within 12 hr of the initial insult
Early seizure/IEE/IIC Clinical seizure/IEE/IIC between 12 hr and 14 days after the initial insult
Late seizure Seizure later than 14 days after the initial insult
Postinjury epilepsy The definition of epilepsy largely follows the current guidelines of the ILAE:
At least two unprovoked (or reflex) seizures occurring >24 hr apart later than 14 days after the
initial insult OR one unprovoked (or reflex) seizure and a probability of further seizures similar
to the general recurrence risk (at least 60%) after two unprovoked seizures, occurring over the
next 10 years (the latter is generally assumed to apply to the post-injury, post-neurocritical care
patient population with neuroimaging-documented lesion)150
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Figure 4. Spreading hyperemia versus spreading ischemia in response to SD. Recordings of a 47-year-old male with WFNS grade 4,
Fisher grade 3 aSAH due to rupture of an anterior communicating artery aneurysm, recording on day 9 after the initial bleeding. (a)
The upper three traces show the large negative DC shift that indicates SD. The SD propagates from electrode 4 to electrode 3 at a
rate of 3.5mm/min and to electrode 5 at 5.6mm/min assuming an ideal linear spread along the strip (band-pass: 0–45Hz). Traces 4–6
show the spreading depression of spontaneous activity in response to SD (band-pass: 0.5–45Hz). Traces 7–9 give the responses of
rCBF to SD as measured with optodes neighboring electrodes 3–5 using laser-Doppler flowmetry.95 Trace ten depicts ptiO2 in
proximity to electrode 5 whereas trace 11 shows CPP which remains within the normal range. The event is interesting since SD
causes spreading hyperemia at optode 3 (¼ normal hemodynamic response). Accordingly, the negative DC shift is short-lasting at
electrode 3. In contrast, spreading ischemia is coupled to the SD at optode 5 (¼ inverse hemodynamic response). Accordingly, the
negative DC shift is longer-lasting and spreading depression of activity is more pronounced and longer-lasting at electrode 5 than at
electrode 3. ptiO2 shows a hypoxic response to SD. Note that the SD starts at electrode 4 but a full-blown inverse response is only
observed at optode/electrode 5. (b) As illustrated in the left panel (refers to the situation at electrode/optode 5 in (a), spreading
(continued)
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implications for the eﬃcacy of therapeutic targeting.
For a more comprehensive account of the diﬀerences
that arise along the SD continuum, we refer the reader
to the following perspectives.1,15,20,45,104,115,175–180
Part 3: Remote detection
of new ischemic zones
Clusters of SD
Following the ﬁrst SD minutes after onset of an ischemic
insult, further SDs develop in the ischemic penumbra in
a recurring pattern that creates the characteristic pattern
of temporal clustering (Figures 2(b), 6, and 7).
Recording of an SD cluster signals newly developing
ischemic damage not only when the recording device is
located in the ischemic zone, but also when it is located
remotely, since SDs also invade surrounding adequately
perfused tissue (Figure 8).105,107,115,165,179–182 The recur-
rent SDs spread not only concentrically from the ische-
mic zone, but they can also cycle around the center if
there is a permanently depolarized core.4,183
Experimental evidence suggests that hypoperfusion or
even increase in CMRO2 by functional activation may
be suﬃcient to trigger recurrent SDs.184 During their
course, they recruit further tissue into death, but the
cumulative local duration of the negative DC shifts
rather than the sheer number of SDs correlated with
the dynamics of infarct growth185 and the ﬁnal infarct
size in animals.182,186
SD clusters are also typically observed in the human
brain in patients with aSAH, ICH, TBI, or MHS
(Figure 6).3,55,91,94,97,116 In patients with aSAH, they
correlated with the advent of DCI and it was found
that they can be associated with new transient or per-
manent neurological deﬁcits such as aphasia or hemi-
paresis.15,55 As a rule of thumb, negative DC shifts of
such clusters become shorter with greater distance from
the ischemic center (Figure 7). Nevertheless, relatively
short-lasting negative DC shifts as in Figure 6 may still
be compatible with development of subsequent damage
at the recording site. Whether or not damage develops
may also depend on whether the DC shifts are
superimposed on a negative ultraslow potential
(NUP). For example, it can be seen at electrodes 5
and 6 in Figure 6 that the DC potential returns to
baseline after the ﬁrst SD of the cluster but then it
becomes mildly negative shortly thereafter (* in
Figure 6). During later course of the cluster, the DC
potential remains within this mildly negative range at
electrodes 5 and 6, and subsequent SDs are superim-
posed on the NUP. By contrast, no such NUP is
observed at electrode 3, which is more distal from the
ischemic center as indicated by the SD spread from
electrode 6 to 3. In animals, NUPs are associated
with incomplete recovery of the typical ion changes
of SD.10,36,105,165 It is assumed, therefore, that the
NUP indicates that only a fraction of neurons in the
tissue has repolarized at the recording site and that the
remaining fraction is persistently depolarized.
SD-induced persistent spreading
depression of activity
Spontaneous electrical activity can only be maintained
in tissue if rCBF is above the range of 15–23mL/
100 g/min.107 An abrupt decrease of rCBF below this
range inevitably causes arrest of spontaneous activity
within several tens of seconds well before ischemia
induces SD (left panel in Figure 8). This arrest of spon-
taneous activity develops simultaneously (¼ non-
spreading depression) in all tissue with a critical rCBF
reduction and is associated with neuronal hyperpolar-
ization, in stark contrast to spreading depres-
sion.2,108,188,189 For a more comprehensive account of
nonspreading depression, we refer the reader to a recent
review.15 Importantly, the ﬁrst ischemia-induced SD
cannot initiate spreading depression in the ischemic
core and inner penumbra because these zones have
already been subject to nonspreading depression and
activity cannot be further depressed. In other words,
the local occurrence of spreading depression of spon-
taneous activity indicates that the level of rCBF is
above 15–23mL/100 g/min and the tissue is not
severely ischemic in the moment when SD invades it
(Figures 5–7).
Figure 4. Continued
ischemia results from a vicious circle in which the sustained neuronal depolarization triggers a perfusion deficit by severe vasocon-
striction. The perfusion deficit leads to energy depletion. The energy depletion causes failure of neuronal and glial membrane pumps.
The failure of the membrane pumps prevents cortical repolarization. Therefore, the release of vasoconstrictors persists which
maintains the process.2,143,144 The prolonged negative DC shift is the necessary electrophysiological criterion that defines spreading
ischemia.2,39 An initial hypoperfusion in response to SD can hence not be rated as a spreading ischemia if is not accompanied by a
prolonged negative DC shift. On the right, a scheme of the normal hemodynamic response to SD is shown for comparison (refers to
the situation at electrode/optode 3 in (a)). Note that normal and inverse hemodynamic responses to SD do not follow an all-or-
nothing principle but show a continuum toward increasing pathology.142 It may also be added that a hyperemic response to SD does
not preclude that the respective SD damages the tissue at the recording site.105,153
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Figure 5. Evolution of a brain infarct early after aSAH. Thirty-eight-year-old male with WFNS grade 5, Fisher grade 3 aSAH due to
rupture of an anterior communicating artery aneurysm. (a) In the left panel, SD of moderate duration is shown that occurred on day 1
after the initial bleeding. Note the negative DC shift propagating from electrode 6 to 5 in traces 5 and 6 (green arrow). The DC shift is
accompanied by spreading depression followed by recovery of the activity in traces 7 and 8 (green arrow). The upper two traces show
MAP (intraarterial line in the radial artery) and CPP (¼ MAP-ICP [intraventricular measurement]). Trace 3 gives rCBF as measured
with laser-Doppler flowmetry (PeriFlux System 5000, Perimed AB, Ja¨rfa¨lla, Sweden) at a distance of 3 cm from electrode 5. Note the
slight increase of rCBF around the time point of SD appearance (upwards pointing red arrow ¼ normal hemodynamic response).
Trace 4 displays ptiO2 as measured with an intraparenchymal oxygen sensor at a distance of about 2 cm from electrode 5.
Autoregulation seems disturbed since the small decrease of MAP and CPP at the end of the recording episode causes a simultaneous
decrease in rCBF and ptiO2. From the beginning, ptiO2 is below the normal range. However, the true value may be somewhat
underestimated by the Licox sensor because Clark-type polarographic probes consume oxygen.172 In the right panel, it seems that
disturbance of autoregulation causes a serious problem shortly after the preceding SD in the left panel. MAP rapidly falls from 120 to
75mmHg and CPP from 105 to 60mmHg (downwards pointing black arrow). Although these values are still in the normal range, rCBF
falls simultaneously by about 30% and ptiO2 falls below the detection limit. About 40s after ptiO2 has reached the lower detection limit
SD starts in electrode 6 in a distance of about 3 cm from the oxygen sensor and spreads to electrode 5 at a rate of 2.1mm/min (traces
5 and 6). In contrast to the preceding SD in the left panel, the negative DC shift only recovers 1 hr later (stars in traces 5 and 6) after
MAP, CPP, rCBF, and ptiO2 have spontaneously recovered to prior levels. Interestingly, the SD in the right panel is associated with
spreading depression of activity in a similar fashion to the preceding SD (traces 7 and 8). This indicates that rCBF must still have been
above 15–23mL/100 g/min at electrodes 5 and 6 when the SD invaded the underlying cortex.107 Most likely, the SD triggered
spreading ischemia in this region. Otherwise it would be difficult to explain why the DC shift was prolonged to such an extent.
Accordingly, rCBF at a distance of 3 cm from electrode 5 now shows a decrease in rCBF around the time point of SD appearance
(downwards pointing arrow ¼ inverse hemodynamic response). Another suspicious decrease in rCBF is seen 20min later. Note also
that spreading depression of activity in traces 7 and 8 is now persistent in contrast to the previous spreading depression in the left
panel. (b) From left to right: the computed tomography (CT) scan on admission (day 0) shows the initial intracerebral hemorrhage.
The red arrow indicates the later position of electrode 6. No evidence of ischemic damage is found in this area on day 0. The next CT
was performed 2 days after the event in (a). The red arrow points to electrode 6 of the subdural recording strip. An electrode artifact
precludes assessment of the recording area in the second CT. However, new infarcts in the territory of the left anterior cerebral
(continued)
14 Journal of Cerebral Blood Flow & Metabolism
With greater distance from the inner ischemic pen-
umbra, nonspreading depression is less and less com-
plete and SD therefore induces increasing degrees of
spreading depression.15 Spreading depression thus
causes the zone of electrically inactive tissue to
expand beyond the inner ischemic penumbra.
Experimental evidence in fact suggests that the zone
of electrically inactive tissue even grows into
surrounding, adequately perfused tissue (right panel
in Figure 8). As SDs originating in the ischemic zone
repetitively invade the surrounding tissue, as explained
above, they keep a belt of adequately perfused tissue
around this ischemic zone in a state of depressed elec-
trical activity. This eﬀect was ﬁrst described in an
experimental model in which ischemia was locally
induced by topical cortical application of the
Figure 5. Continued
artery and right temporal lobe are observed. The third picture shows a fluid attenuated inversion recovery (FLAIR) MRI on day 9. In
addition to the territorial infarct in the left anterior cerebral artery territory, cortical necroses in the right frontal recording area,
anterior cortex neighboring the interhemispheric cleft, insular and parietotemporal cortex are observed. The fourth picture gives the
FLAIR image at 7 months depicting the widespread brain infarcts including the recording area. At this time point the patient showed
severe left-sided hemiparesis and lower moderate disability on the extended Glasgow Outcome Scale.
Figure 6. Persistent spreading depression of spontaneous activity can be associated with short-lasting, very stereotypical SDs. Fifty-
seven-year-old male with WFNS grade 1, Fisher grade 3 aSAH due to rupture of an MCA aneurysm. Traces 1–5 give the raw ECoG
recordings (band-pass: 0–45Hz) at electrodes 2–6 showing the propagation of stereotypical negative DC potential shifts across the
cortex indicating a cluster of SDs (oblique arrows). Traces 6–10 display the changes in spontaneous activity in the AC-ECoG
recordings (band-pass: 0.5–45Hz). Note that the first SD is an isoelectric SD at electrode 6 but a spreading depression at electrodes
2–5. From one SD to the next, the isoelectricity then expands in the tissue so that the third SD is only a spreading depression at
electrode 2 but an isoelectric SD at electrodes 3–6. In other words, spreading depression causes the zone of electrically inactive tissue
to grow. Experimental evidence in fact suggests that the zone of electrically inactive tissue can even expand into surrounding,
adequately perfused tissue. This view is supported here by the observation that, for example, the third negative DC shift at electrode
3 is indistinguishable from the second one although the third SD is an isoelectric SD but the second SD a spreading depression at
electrode 3. Another interesting detail is that electrodes 5 and 6 are significant for a shallow negative DC shift between the recurrent
SDs (*). This could represent a NUP as explained in the text. Modified with permission from Oliveira-Ferreira et al.105
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vasoconstrictor endothelin-1 (ET-1).105 rCBF and
ECoG were recorded both in the cranial window of
ET-1 application and at a second window remote
from the ischemic zone, where persistent depression
developed as a result of invading SDs. The same
eﬀect is also evidenced in the middle cerebral artery
occlusion (MCAO) model as seen, for example, in
Figure 2 in the article by Dijkhuizen et al.182 and
Figures 1(c) and 4 in the article by Hartings et al.190
Clinical observations are consistent with these
experimental results. In patients, clusters of SDs often
lead to persistent depression of electrical activity
(Figure 6), and several lines of evidence suggest that
these patterns develop in nonischemic cortex. First, in
a large majority of these cases, the depression starts in a
spreading rather than nonspreading manner (Figures 6
and 7), demonstrating that SD, rather than pre-existing
ischemia, is the cause of depression. Second, most of
these SDs in electrically inactive tissue have DC shifts
of short duration, similar to SDs that induce spreading
depression in spontaneously active tissue
(Figure 6).91,105 Third, ptiO2 preceding SD was similar
and diﬀerences in ptiO2 responses to SD were only
subtle between SDs in electrically inactive tissue and
SDs in electrically active tissue.64 Fourth, the N-
methyl-D-aspartate receptor (NMDAR) antagonist
ketamine was suﬃcient to block clusters of SDs in elec-
trically inactive tissue, such that spontaneous activity
Figure 7. Development of a very prolonged negative DC shift during a cluster of recurrent SDs. Fifty-one-year-old female with
WFNS grade 5, Fisher grade 3 aSAH due to rupture of an MCA aneurysm.
Traces 1–4 show the raw ECoG (band-pass: 0–45Hz) of electrodes 3–6. Note the long-lasting negative DC shift propagating from
electrodes 6 to 4 which develops out of the cluster and lasts for 90min at electrode 6. Traces 5–8 give the corresponding changes of
the AC-ECoG activity (band-pass: 0.5–45Hz). Note that the depression durations become progressively longer with each SD until a
persistent depression of AC-ECoG activity develops simultaneously with the very prolonged negative DC shifts. Traces 9 and 10 show
recordings of rCBF using optodes close to electrodes 3 and 4. In trace 10, note that rCBF displays a prolonged decrease followed by a
delayed hyperemia in response to the long-lasting SD at electrode 4 (cf. * in traces 2 and 10). This rCBF response fulfills the criteria of
spreading ischemia. By contrast, in trace 9, the rCBF responses to the last SDs are characterized by increases, and the corresponding
SDs in trace 1 (electrode 3) are shorter-lasting. ptiO2 is shown in trace 11 and CPP in trace 12. CPP remains within the normal range
and does not provide an explanation for the local events. However, ptiO2 is below 15mmHg which is defined as the threshold of
compromised ptiO2 following current guidelines.
187 Note that a decline of ptiO2 starts with the fourth SD while CPP remains stable
(cf. ‘‘x’’ in traces 4 and 11). The recorded SDs start from electrode 6 and the prolongation of the negative DC shifts was most
pronounced at this electrode. Consistently, electrode 6 was closer to a large intracerebral hemorrhage which showed progression of
the perilesional edema in serial neuroimages. Modified with permission from Oliveira-Ferreira et al.105
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Figure 8. Pathophysiology of focal cerebral ischemia. In the experimental literature, the ischemic core has been roughly defined
by a perfusion level below 15mL/100 g/min, the inner penumbra (ip) by a perfusion level below 20mL/100 g/min and the outer
penumbra (op) by a perfusion level below 55mL/100 g/min (a).107 The first electrophysiological change in response to ischemia
is nonspreading depression of activity15 which is complete in core and inner penumbra about 30–40 s after the onset of ischemia
(c, left panel). At this time point, ischemia has not induced SD yet. The first SD starts in the ischemic core at one or more points in the
tissue typically 2–5min after the onset of ischemia.108 In the core, the negative DC shift is usually persistent but its duration
becomes progressively shorter-lasting along its path in the tissue while the SD spreads against the gradients of oxygen, glucose and
perfusion into the adequately supplied surrounding tissue (b, right panel). With greater distance from the inner ischemic penumbra,
nonspreading depression is less and less complete and SD therefore induces increasing degrees of spreading depression.15 Spreading
depression thus causes the zone of electrically inactive tissue to expand beyond the inner ischemic penumbra. Experimental evidence
suggests that the zone of electrically inactive tissue even grows into surrounding, adequately perfused tissue (c, right panel). Following
the first SD after onset of an ischemic insult, further SDs develop in the ischemic zone in a recurring pattern that creates the
characteristic pattern of temporal clustering. A subdural electrode strip may thus detect newly developing ischemic zones via
(i) clustered SDs and/or (ii) impaired recovery of spontaneous activity even if the recording device is placed remotely from the
ischemic zone. In the figure, electrodes 1 and 2 would show a cluster of isoelectric SDs although the strip is located outside of
the ischemic zone.
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returned.139,191 If inactivity had been ischemia-induced
nonspreading depression rather than SD-induced per-
sistent spreading depression, the activity should not
have returned after blockade of the cluster. Also, the
NMDAR antagonist would not have been suﬃcient to
block the cluster in more severely energy deprived
tissue, as shown in animal studies192–195 and a case
report.95
Persistent SD-induced depression of electrical activ-
ity causes a large increase of the total depression dur-
ation of the respective recording day (cf. below). This
variable demonstrated the strongest association with
patient outcome among various quantitative measures
of SD burden.58,64
Isoelectric SDs
SDs in electrically inactive tissue are denoted with the
adjective ‘‘isoelectric’’ (Figures 2(b), 6, and 7). The con-
cept above suggests that isoelectric SDs can be recorded
both in tissue with and without local energy depriv-
ation. Nevertheless, isoelectric SDs indicate that there
is energy deprivation somewhere in the tissue, even if
not at the recording site (Figure 8). Consistent with this
interpretation, isoelectric SDs were associated with a
highly signiﬁcant eightfold increase in the risk of
unfavorable outcome at 6 months in a prospective,
observational multicenter study of patients with TBI,
in contrast to SDs in electrically active tissue.57
These ﬁndings suggest that, in addition to the cluster-
ing of SDs,55,116 the recording of isoelectric SDs55,90,91 or
SDs with signiﬁcantly prolonged depression dur-
ations55,58,90 has great value to remotely detect newly
developing ischemic zones. Remote diagnosis of new
ischemic zones is of particular relevance to patients
with acute brain injury because the exact location of
future developing pathology is usually unknown when
the neurosurgeon implants neuromonitoring devices. It
is also a particular advantage of ECoG over other neu-
romonitoring modalities, such as microdialysis and ptiO2
measurements, that measure only local conditions and
may not detect clinically important changes developing
elsewhere in an injured lobe or hemisphere.116
Part 4: Recommendations of the
COSBID study group on how
to record, score, and classify SDs
Subdural ECoG recordings and minimally invasive
alternatives: Technical aspects
The current gold standard for monitoring SDs in the
clinic is ECoG with a linear subdural platinum electrode
strip. The one most widely used contains six platinum
contacts with 4.2mm2 exposed surface spaced at 10mm
along the strip (Wyler, 5mm diameter, Ad-Tech, Racine,
WI, USA). The strip is placed subdurally on the surface
of the cortex to monitor viable tissue at risk for second-
ary injury. In patients with aSAH the strip is targeted to
the vascular territory of the aneurysm-carrying ves-
sel55,58,95,96,196 because it is often covered with blood
and, thus, a predilection site for DCI.197,198 In TBI,
the strip is placed on peri-contusional cortex or sub-
jacent to an evacuated subdural hematoma,57,90,91,161,199
in ICH on perihematomal cortex94 and in MHS on peri-
infarct cortex.4,97 Ground is provided by a platinum
needle (Technomed Europe, Maastricht, Netherlands
or Grass Technologies, Warwick, RI, USA) or
Ag/AgCl scalp electrode, or more simply, a self-adhesive
Ag/AgCl patch electrode on the shoulder.161,196 For DC
referential recordings, a platinum needle or Ag/AgCl
sticky electrode is placed for a reference, usually on the
mastoid or frontal apex away from muscle attachments.
Recordings are usually performed for up to 14 days in
aSAH and 7 days in other conditions.
The tail of the electrode strip is tunneled subcutane-
ously beneath the scalp and exited 2–3 cm from the cra-
niotomy scalp incision. It should then be coiled and
sutured to the scalp to provide strain relief and guard
against accidental displacement. When the strip is
implanted after craniotomy, the previously removed
bone ﬂap may be re-secured with a titanium clamp or
plating system followed by standard wound closure
paying special attention not to place any sutures
around the electrode. Notably, the neurosurgeon
should be aware of the following pitfalls: (a) gentle trac-
tion may not be suﬃcient to remove the strip after the
monitoring period when the strip is trapped/pinched by
the bone ﬂap or the titanium ﬁxation, or the subcutane-
ous tunnel is too tight; (b) a cerebrospinal ﬂuid (CSF)-
ﬁstula may develop. Therefore, the following precau-
tions should be taken: (a) suﬃcient bone should be
removed with an osteotome or rongeur where the tail
of the strip exits and through which the strip is with-
drawn by gentle traction at the end of monitoring; (b)
the tail of the strip should exit the craniotomy and scalp
in line with the electrode strip and not be curved or bent
at an angle; (c) no plating hardware should be used next
to the location of the strip; and (d) the subcutaneous
tunnel should be prepared suﬃciently long and dilated,
for example, with a Halsted-Mosquito clamp. To avoid
a CSF-ﬁstula, an additional fully penetrating skin suture
should be performed at half-distance from the scalp exit
point and a suﬃcient amount of absorbable hemostatic
gelatin sponge should be placed under the bone ﬂap,
particularly in the area of the strip. Antibiotic treatment
beyond standard preoperative prophylaxis is not
recommended.
Analysis of 30 patients with severe aSAH who
received a subdural strip for ECoG recordings and 30
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control patients showed no evidence that procedures of
the ECoG study led to any signiﬁcant impairment
of patients as assessed during clinical course and
follow-up examination after 6 months. In particular,
the subdural strip did not lead to any increased rate
of hemorrhage or local damage of brain tissue as
assessed through serial neuroimaging studies by a neu-
roradiologist or meningitis/ventriculitis.75
For patients who do not require craniotomy for
treatment of their injuries, it is also possible to place
a subdural electrode strip through a burr hole. This has
been routinely practiced in aSAH patients undergoing
endovascular coil embolization at German neurosurgi-
cal centers for almost a decade,95,196 and for even
longer in patients with intractable epilepsy.200,201
Another option is to monitor with an intraparenchymal
electrode array (Spencer, 1.1mm diameter, Ad-Tech,
Racine, WI, USA) that can be tunneled from a burr
hole or placed through a multi-lumen bolt, as is cus-
tomary practice for ICP and ptiO2 monitoring.
202,203
Such intraparenchymal sensors show a good safety pro-
ﬁle. In a case series of 61 patients with acute brain
injury undergoing invasive parenchymal brain monitor-
ing, including use of depth electrodes, hemorrhage, and
infections were rare.204 The risk of a CSF-ﬁstula is
lower with a depth electrode compared to a subdural
strip.
Yet, subdural strips also have advantages over intra-
parenchymal devices that inevitably cause minor necro-
sis at the insertion site. Histological and
immunohistochemical analysis of brain tissue surgically
resected from epilepsy patients suggested, for example,
that depth electrodes cause upregulation of active
inﬂammatory cell types and extravasation of plasma
proteins, indicating signiﬁcant local disruption of the
blood-brain barrier (BBB), in an area that is 30 times
the area of the physical insult.205 Subdural electrode
strips not only avoid this local insult, which might inﬂu-
ence measured signals, but also permit recording from a
larger cortical area. A study in this issue found that
monitoring only a single cortical location, as with an
intraparenchymal depth array, may fail to capture 43%
of SDs that occur in a broader area of subdural strip
monitoring.120 Further, DC potential measurements
with intraparenchymal electrodes might be strongly
inﬂuenced by the large and complex SD-triggered
changes in pH and ptiO2, which are less pronounced
in the microenvironment of the cortical surface away
from neurons. For example, pH typically changes by
about 0.5 units9,10 and ptiO2 by up to 30mmHg in the
cortex during SD,95,96,161 and such changes generate
large and complex interfering voltage shifts on plat-
inum electrodes. Caution is however warranted regard-
ing both subdural and parenchymal implants in
patients receiving antiplatelet agents or having low
platelet counts or dysfunctional platelets or other rea-
sons for a bleeding diathesis.
Although Ag/AgCl and calomel electrodes are ideal
for recording low-frequency potentials due to their
resistive and nonpolarizing character, their toxicity pre-
cludes use for invasive recordings in patients.206
Platinum electrodes by contrast are polarizable, and it
has been assumed that this capacitive behavior distorts
low frequency and DC potentials. Thus, clinical ECoG
monitoring has been accomplished mainly with AC-
coupled ampliﬁers with a 0.01–0.02Hz lower frequency
limit. It has only more recently become clear that DC-
coupled ampliﬁers can be used for continuous ECoG
monitoring as well, with the great advantage that DC
shift durations can be measured, as discussed here and
shown in the ﬁgures.16,58,95,196,207 The surprisingly high
ﬁdelity in recording these slow potentials is explained
by the large contact area of electrodes and the high
input impedance of ampliﬁers.208 The practical experi-
ence of DC recordings suggests that they are a suitable
substitute for AC techniques and are fully consistent
with the present recommendations.120
Nonetheless, it would be worthwhile to explore
better electrode materials for invasive human applica-
tions and, beyond subdural recordings, noninvasive
technologies such as continuous scalp EEG should be
further advanced.209 Although correlates of SD were
clearly identiﬁed in continuous scalp EEG recordings
when performed simultaneously with subdural
ECoG,196,210 scalp EEG alone is not yet suﬃcient to
reliably diagnose SDs and further studies of the com-
bined technologies are strongly recommended. Scalp
EEG may hold particular promise for noninvasive
monitoring of SD if it is combined with other noninva-
sive technologies, such as near-infrared spectroscopy or
diﬀuse correlation spectroscopy, that measure rCBF or
its surrogates.211,212
Terminology. In the following and Table 1, we provide a
set of terms that describe the various patterns of activ-
ity related to SD, based solely on observations from
human recordings,15 and without implied meaning,
assumption of underlying mechanisms, or presumed
eﬀect on the tissue. We recommend use of these neutral
terms and classiﬁcations as a common clinical language
and to objectively evaluate hypotheses concerning the
application of SD monitoring. In our opinion, terms
such as spreading depression-like depolarization, peri-
infarct depolarization, or brain injury depolarization
have their historical place, but are either nonspeciﬁc
or overly speciﬁc with connotations that may hinder
objective analysis of the clinical data. Speciﬁcally,
they obscure the fact that all SDs belong to the same
class of waves which exist on a continuum and occur
across a wide variety of clinical conditions.15,45
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It is also emphasized that there are striking neuro-
biological diﬀerences between ‘‘depression’’ and
‘‘depolarization’’ as explained above. In fact, depressed
activity can be associated with either neuronal depolar-
ization (spreading depression) or neuronal hyperpolar-
ization (nonspreading depression).189 Although the
terms depression and depolarization are often used
interchangeably, awareness of the distinction between
them is the key to understanding their divergent clinical
implications. Furthermore, SD can occur without
spreading depression, but not vice versa. Therefore,
the term spreading depression should only be used if
spreading depression of spontaneous activity is actually
recorded.
Anoxic, asphyxial, and aglycemic SD are special
cases at the extreme end of the SD continuum.
Historically, they refer to the initial SD that is triggered
by the corresponding insult, such as vascular occlusion
and consequent severe ischemia in the case of anoxic
SD.173,213,214 In such cases, energy compromise causes
nonspreading depression of activity up to minutes
before it causes SD, as explained above and shown in
the left panel of Figure 8. However, anoxia/ischemia
may also occur during SD in a manner that is distinct
in both mechanism and electrophysiologic signature.
Speciﬁcally, if the hemodynamic response to SD is
inverted, SD can cause a severe ischemia (and hence,
anoxia) that begins only after the onset of SD.39 In such
cases, SD can induce spreading depression of activity in
the electrically active tissue that it invades (Figure 5).2
Notably, the mechanisms responsible for anoxia/ische-
mia in these two conditions are very diﬀerent, and for
this reason we discourage use of anoxic SD or terms
alike because they are ambiguous. Rather, we advocate
properly describing and quantifying electrophysio-
logical variables including the DC shift duration and
amplitude and the depression pattern of a given SD to
distinguish these conditions in an objective manner. In
addition, invasive measurements of arterial pressure
and local tissue ptiO2 can be informative by providing
evidence of global arrest of the circulation and tissue
anoxia, respectively. Further, serial neuroimages of
delayed infarction in the recording area may provide
post hoc evidence that SDs occurred in conjunction
with severe focal hypoxia/ischemia. Figure 5 gives a
good example for the complexity of such events.
Practical recommendations on how to record, score,
and classify SDs
Box 1 summarizes the work ﬂow of the basic analysis as
explained below.
SD is used as the generic term for all waves in the
human ECoG characterized by an abrupt, negative DC
shift with sequential onset in adjacent electrodes
(Figures 5 and 7).55,90 Assessment of the raw DC shift
can only be achieved if the ampliﬁer is DC-coupled,
that is, has no lower frequency limit. With an AC-
coupled ampliﬁer with lower frequency limit of 0.01
or 0.02Hz, the cortical DC shift of SD is distorted by
the ﬁltering190,215 but is still recorded as a stereotyped
slow potential change (SPC) that serves as a hallmark
signature of SD.90,215 The AC-recorded SPC thus
merely serves as an identiﬁer of SD,55,90 whereas the
unﬁltered DC shift also allows assessment of the local
duration of SD and is a useful measure for (a) the tissue
energy status and (b) the risk of injury (excitotoxicity)
at the recording site, as explained above
(Figure 3(c)).1,91,95,105,108,115 Hereafter, use of the term
DC shift should be understood to refer also to SPC
when AC-coupled ampliﬁers are used.
After recording, ECoG data are reviewed with the
use of software such as LabChart (ADInstruments,
Oxford, UK), a ﬂexible platform that provides ﬁltering
and other signal processing functions and allows mul-
tiple display views. Here, DC shifts and depression dur-
ations can be observed in either monopolar (¼ unipolar
¼ referential) (Figure 3(a) and (c)) or bipolar record-
ings (Figure 3(b)). In the bipolar ECoG montage, elec-
trode 2 is subtracted from electrode 1, electrode 3 from
2, and so on. In the monopolar montage each electrode
is referenced to an ipsilateral subdermal platinum elec-
trode. Monopolar recordings are superior to bipolar
recordings when local information on individual elec-
trodes is of interest. In particular, the duration of DC
shifts can only be reasonably evaluated in monopolar
recordings. However, bipolar recordings provide a safe-
guard in the clinical setting in case the external refer-
ence for monopolar recordings is displaced during
patient movements or nursing procedures. SD-induced
depression durations and isoelectric SDs can be
assessed in both bipolar and monopolar recordings,
which is fortunate because these variables are import-
ant for diagnosis of new ischemic zones, as explained
above. While bipolar recordings have been the most
commonly used clinical standard, monopolar assess-
ment of depression durations may be more useful for
direct comparison to DC shifts.120
SD-induced spreading depression is observed
between neighboring electrodes as a more or less rap-
idly developing, propagating reduction in the raw amp-
litude of spontaneous activity in the 0.5–45Hz band, or
any derived measure based on amplitude. Our conven-
tion has been to review the raw signal alongside a leaky
integral of the total power of the bandpass ﬁltered (AC-
ECoG) data and measure depression duration based on
the latter (Figure 3(a) and (b)). Table 2 provides simple
commands in LabChart to set digital ﬁlters and calcu-
late power of the spontaneous activity and leaky inte-
gral of the power based on the raw data.55,58
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Accepted minimal standards for scoring an event as
SD requires either: (a) when using a DC-coupled
system, an event which has a characteristic DC shift
associated with spreading depression of spontaneous
activity even if DC shift and spreading depression are
restricted to a single channel; or (b) that there are char-
acteristic, time-shifted DC changes (Figures 1–7) in two
or more adjacent channels occurring within 10min of
Box 1. Basic analysis of baseline activity, SDs and IEEs in neurocritical care.
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Table 2. Basic analysis of SDs/settings in LabChart software (ADInstruments).
Task Description of the traces Arithmetic calculation in LabChart
Identification of SDs through DC shifts
that propagate between adjacent rec-
ording sites (Figures 1 and 3)
Raw DC-ECoG or near-DC-
ECoG with 0.01Hz frequency
limit
No calculation
Assess DC shift duration120 Raw DC-ECoG No calculation
Assess spontaneous activity, IEEs, IIC, and
identify SD-induced spreading
depressions
Raw ECoG filtered at 0.5–45Hz
to observe spontaneous
activity
bandpass(rch[no],0.5,45) [English version]a
bandpass(rch[no];0,5;45) [German version]
Intermediate step (changes of power and
integral of the power in % are almost
interchangeable but the power is less
sensitive to artifacts; thus, the power can
be used to estimate changes in AC-ECoG
activity over time in % (during spreading
depressions, IEEs, etc.) to avoid missing
values when artifacts preclude the use of
the integral of the power)
Power of the AC-ECoG signal at
frequencies between
0.5 and 45Hz
bandpass(rch[no],0.5,45)^2 [English]a
bandpass(rch[no];0,5;45)^2 [German]
Quantify the decline in AC-ECoG activity
during spreading depression in % and
measure spreading depression duration
as explained in Figure 3(a) and (b)
Integral of power of the ECoG
signal at frequencies between
0.5 and 45Hz
integrate(bandpass(rch[no];0,5;45)^2;’’decay’’;60)a
integrate(bandpass(rch[no];0,5;45)^2;’’decay’’;60)
Definition of days post-injury The first 24 hr period after the initial insult is denoted as ‘‘day 0,’’ the second 24 hr
period as ‘‘day 1’’ and so on58
Total SD-induced depression durations per
recording days (TDDD)
The sum of the longest depression durations of all individual SDs during each 24 hr
period is calculated. If there is temporal overlap between depression periods of
successive SDs on different electrodes, the overlapping period is only counted once.
TDDD is defined as the value after normalization to the total time of valid
recordings during that 24 hr period. For instance, if 240min (4 hr) of total depres-
sion duration are recorded in 22 hr of a 24 hr period, the normalized TDDD is
262min [(4/22) 24 60].
Peak total SD-induced depression duration
of a recording day (PTDDD)
Longest TDDD among all recording days in a given patient
Assess isolated SDs and clusters For each SD, the time interval to the preceding SD should be determined. Current
working definition of a cluster is the occurrence of at least three SDs occurring
within three or fewer consecutive recording hours.139
Assess isoelectric SDs Identification of SDs in electrically inactive tissue requires the combined evaluation of
the negative DC shift in the DC-ECoG and the lack of spontaneous activity before
the onset of SD in the AC-ECoG (bandpass: 0.5–45Hz) (Figure 2(b)).
Assess spreading convulsions Requires the combined evaluation of the negative DC shift in the DC-ECoG and the
identification of epileptic field potentials on the tailing end of the DC shift58,109,121 in
the AC-ECoG (bandpass: 0.5–45Hz) (Figure 3(d))
Assess IEEs Determine the duration of each IEE from first to last epileptiform event using the raw
ECoG filtered at 0.5–45Hz. Calculate the total IEE duration of each recording day
and the peak total IEE duration of all recording days in analogy to the TDDDs and
the PTDDD for SDs.
After scoring the patient recording, total numbers of SDs (spreading depressions plus isoelectric SDs plus spreading convulsions),
spreading depressions alone, isoelectric SDs alone, spreading convulsions alone and IEEs can be calculated. Importantly, these
numbers should be normalized or reported with respect to the duration of valid recording. It is recommended, for instance, to
calculate numbers per recording day and peak number per recording day, as for TDDD and PTDDD above. These summary
measures can then be examined in relation to baseline injuries, neurologic exam, interventions, serial neuroimaging-assessed lesion
development, patient outcome, late epilepsy, or other clinical measures.
Minimal requirements to diagnose SD: (i) Characteristic DC shift with associated spreading depression of spontaneous activity on a
single channel if acquired with a DC-coupled amplifier, OR (ii) nonsimultaneous characteristic DC shift/SPC occurring in two or
more electrodes within 10min of each other; in addition, spreading depression of activity should be observed in at least one
channel unless the tissue is electrically inactive, OR (iii) similar pattern of DC shift/SPC as recorded at a different time in the same
patient. Depression of activity or shape of DC shift/SPC may be more irregular or artifact laden.
aNote that the punctuation may vary according to the country settings.
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each other; in addition, spreading depression of activity
should be observed in at least one channel if the tissue is
electrically active.
Identiﬁcation of SDs is usually straightforward after
training to distinguish the characteristic waveforms from
other confounding physiologic or artifactual changes.120
In cases of doubt, it is often useful to screen all record-
ings of a given patient because SDs have been observed
to frequently repeat in a stereotyped pattern. Some
events following the same pattern may be more easily
identiﬁed as SD than others. Once the pattern is under-
stood it is easier to see all SDs. If the same pattern of DC
shifts is observed to repeat, an event may even be scored
as SD if the above criteria are not as readily visible (e.g.,
artifact interferes with the DC shift on one or more
channels). Diagnostic accuracy can further be improved
in diﬃcult cases when typical responses of ptiO2 or rCBF
to SD are available (Figures 2, 4, and 7). However, if
signiﬁcant doubt remains we strongly recommend that
questionable events are not scored as SDs to avoid false
positives. DC shifts that occur simultaneously across all
leads, or those occurring with instantaneous changes
rather than smooth contours, should never be con-
sidered SD.
Events should be scored as a new event if a subse-
quent DC shift at a given electrode can be scored as an
independent event per the criteria above. This may be
particularly relevant in quickly recurrent events, and
since repeated events and clusters are important prog-
nostic factors, they should be accurately recorded.
Currently, NUPs are not routinely scored due to diﬃ-
culty in diﬀerentiating from drift in DC systems.
For each SD, the depression durations are calculated
in minutes for each channel, as shown in Figure 3(a)
and (b). Only depressions observed to be induced by
SD are included. Among all depression durations in
individual channels, the longest is then determined for
each SD. Subsequently, the total depression duration of
each 24 hr period following the initial insult is calcu-
lated as the sum of the longest depression durations
of all individual SDs during that 24 hr period. If there
is temporal overlap between depression periods of suc-
cessive SDs on diﬀerent electrodes, the overlapping
period is only counted once. The ﬁrst 24 hr period is
usually denoted as ‘‘day 0,’’ the second 24 hr period as
‘‘day 1,’’ and so on.58 Subsequently, the total depres-
sion duration of each day (TDDD) is deﬁned as the
value after normalization to the total time of valid
recordings during that 24 hr period.64 For instance, if
240min (4 h) of total depression duration are recorded
in 22 hr of a 24 hr period, the normalized TDDD is
262min [(4/22) 24 60]. The peak total depression
duration per recording day (PTDDD) is then deﬁned
as the longest TDDD among all recording days in a
given patient.
The basic ECoG analysis also dichotomizes between
SDs in electrically active tissue that receive the epithet
‘‘spreading depression’’ and SDs measured in a zone of
electrically inactive tissue, denoted with the adjective
‘‘isoelectric.’’91 Even if the DC shift arises from electric-
ally inactive tissue in only one channel, the SD is docu-
mented as being isoelectric (e.g., Figure 6). Deﬁnitions
of IEE and ictal-interictal continuum (IIC) are given in
Table 1. If epileptiform ﬁeld potentials arise on the
tailing end of the DC shift this should be documented
as ‘‘spreading convulsion’’ which is a historical term
based on van Harreveld and Stamm (Figure
3(d)).58,109,121 If a spreading convulsion occurs in iso-
electric tissue it may also be documented as ‘‘isoelectric
SD’’ depending on the scope of the study. The caveat is
added that pulse artifacts are often observed during the
DC shift of isoelectric SDs and should not be mistaken
for epileptiform ﬁeld potentials.58
After scoring the patient recording, total numbers of
SDs (spreading depressions plus isoelectric SDs plus
spreading convulsions), spreading depressions alone,
isoelectric SDs alone, spreading convulsions alone,
and IEEs can be calculated. Importantly, these num-
bers should be normalized or reported with respect to
the duration of valid recording. It is recommended, for
instance, to calculate numbers per recording day and
peak number per recording day, as for TDDD and
PTDDD above. These summary measures can then be
examined in relation to baseline injuries, neurologic
exam, interventions, serial neuroimaging-assessed
lesion development, patient outcome, late epilepsy, or
other clinical measures.
Nonspreading depression is observed as a simultan-
eous arrest of spontaneous activity in neighboring elec-
trodes. However, the criteria of nonspreading
depression are only fulﬁlled if either invasive measure-
ments of arterial pressure prove a global arrest of the
circulation or local measurements of ptiO2 indicate
severe tissue hypoxia/ischemia. Otherwise, the nature
of this ECoG pattern remains ambiguous.
A basic neuromonitoring protocol should also
include, at least, recordings of arterial pressure, ICP,
CPP, and body or brain temperature that can be
reviewed together with ECoG data. Particularly with
high-resolution (waveform) recordings, these variables
can assist in deciphering cause and eﬀect of multivariate
physiologic changes, and are further helpful in identiﬁ-
cation of ECoG artifacts. Baseline values can also be
documented at regular intervals to chart the course of
neuromonitoring variables in relation to SDs. ptiO2
recordings with a sensor based on either polarography
or luminescence quenching are also inform-
ative.63,216–219 When the sensor is located next to the
electrode strip, ptiO2 responses to SD should be exam-
ined in a small range of 6min around time points of
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SD appearance.96 The ptiO2 level immediately preced-
ing SD and at least amplitude and duration of the ini-
tial change of ptiO2 in response to SD should be
analyzed. The initial change of ptiO2 can show either
a decrease, no change or an increase.95,96 The ptiO2
level immediately preceding SD was previously deﬁned
as the mean ptiO2 level in the 5min period prior to each
SD.184 Simultaneously, CPP, mean arterial pressure
(MAP) and ICP can also be documented.
Conclusion
After many decades of frustration, it has turned out to
be surprisingly simple to record SDs from the human
brain with minimally invasive technology.89,92 Now it
is time to make use of one of the most phylogenetically
preserved and fundamental pathological phenomena of
the brain to advance understanding of human dis-
ease.220,221 For this purpose, the recommendations pro-
posed here have been developed based on our
cooperative studies for more than a decade. Further
insight into clinical application, less invasive approaches,
and automation of procedures are likely to render SD
monitoring an increasingly potent tool for real-time
diagnosis of disturbed brain energy metabolism and
lesion development in neurocritical care.
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